TG Therapeutics to Present at Cantor Global Healthcare Conference.

TG Therapeutics Inc (TGTX) announced participation in the Cantor Global Healthcare Conference on September 3, 2025. CEO Michael S. Weiss will participate in a fireside chat, available via live webcast on the company's website. The event highlights the company's successful product development, including approval of BRIUMVI® for multiple sclerosis treatment in the U.S. and Europe. Investors may seek more detailed information on the company's financial performance and future product pipeline during the fireside chat.

TG Therapeutics Inc (TGTX) has announced its participation in the Cantor Global Healthcare Conference on September 3, 2025. The event will feature CEO Michael S. Weiss in a fireside chat, available via live webcast on the company's website. This event provides an opportunity for investors to gain insights into TG Therapeutics' financial performance and future product pipeline.

During the fireside chat, CEO Michael S. Weiss is expected to discuss the company's recent achievements, including the approval of BRIUMVI® for the treatment of multiple sclerosis in both the U.S. and Europe. The event will also cover the company's ongoing product development efforts and future strategic directions.

Investors can expect to hear more about the company's financial health and prospects for growth, which are crucial for making informed investment decisions. The fireside chat will provide a platform for Weiss to address questions from analysts and investors, offering a more detailed look into the company's operations and future plans.

The participation in the Cantor Global Healthcare Conference underscores TG Therapeutics' commitment to transparency and engagement with the investment community. By sharing updates and insights, the company aims to build confidence among stakeholders and provide clarity on its growth trajectory.

For more information about TG Therapeutics Inc (TGTX), including the latest stock price and other financial data, please visit the company's website or the NASDAQ stock exchange page.

References:
[1] https://parameter.io/coreweave-crwv-stock-rallies-on-cantor-fitzgeralds-bullish-ai-forecast/
[2] https://www.morningstar.com/news/business-wire/20250827264017/hope-biosciences-secures-fda-rmat-designation-for-stem-cell-therapy-in-relapsing-remitting-multiple-sclerosis
[3] https://www.investing.com/equities/tg-therapeutics-inc